Financial Consulate’s AMN Healthcare AMN Stock Holding History

Financial Consulate’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25	Closed	-$484	–	1348
2025 Q3	$484	Buy	+25	New	+$488	﹤0.01%	1018

Other funds holding AMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Consulate's AMN Position: Q4 2025 in Review

Financial Consulate sold out of AMN Healthcare (AMN) in Q4 2025, closing a stake of 25 shares — an estimated $484 sold.

Financial Consulate first reported a position in AMN in Q3 2025 and held it in 1 quarter. The position peaked at $484 in Q3 2025. 236 funds tracked by Wall St. Rank hold AMN as of Q4 2025.

Financial Consulate reported no remaining AMN Healthcare position as of Q4 2025 after selling out during the quarter.
Financial Consulate sold 25 AMN Healthcare shares in Q4 2025, an estimated $484.
Financial Consulate first reported a position in AMN Healthcare in Q3 2025 and held it in 1 quarter.
Financial Consulate's AMN Healthcare position peaked at $484 in Q3 2025.
236 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2025.

Based on Financial Consulate's 13F filing for Q4 2025, filed 22 Jan 2026.